Endocrine Abstracts

Introduction: Individuals with type 1 diabetes have an increased risk of depression, which can worsen their health condition and elevate the risk of complications. This study aims to estimate the prevalence of anxiety and depression in these patients and evaluate their impact on disease management.

Patients and Methods: A retrospective study over six years (2018-2023), including 168 hospitalized type 1 diabetic patients, assessed for their mental state using the Hamilton and Beck scores. Statistical analysis was performed using Epi-Info 7.2 software.

Results: The mean age of the patients was 26 years, with a sex ratio of 1.3 males to 1 female. The prevalence of toxic habits was 39.2%. The average diabetes duration was 8.5 years, and glycemic imbalance was observed in 88.6% of patients. Degenerative complications (retinopathy, nephropathy, neuropathy) were present in a quarter to a third of patients. Acute complications (ketosis, acidosis, frequent hypoglycemia) were very common, affecting 89.8%, 32.1%, and 82.1% of patients, respectively. Depression and anxiety were present in 20.2% and 61.3% of patients, respectively, with co-occurrence observed in 18.4%. Diabetes and anxiodepressive disorder follow-up were irregular in 78.3% of cases. Treatment mainly included supportive psychotherapy, as well as anxiolytics and antipsychotics as needed.

Conclusion: Detecting anxiodepressive disorders in the management of type 1 diabetic patients is of paramount importance. Appropriate psychological intervention could promote better glycemic control and more effective disease management.